| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.99B | +37.4% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | -46.4% |
| Gross margin | 10.1% | Net margin 4.1% |
| Revenue Q/Q | -21.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.89B | 89.9% |
| R&D | ¥0.01B | 0.7% |
| SG&A | ¥0.04B | 4.1% |
| Tax & other | ¥0.01B | 0.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
名家汇 ・ 苏奥传感 ・ 维宏股份 ・ 新美星 ・ 金冠股份 ・ 雪榕生物 ・ 中亚股份 ・ 恒实科技 ・ 友讯达 ・ 三德科技 ・ 久之洋 ・ 海波重科
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies